View Press Releases
RxTE Health Appoints Dave Teckman as Executive Chairman of the Board
SACRAMENTO, CA, UNITED STATES - Feb 13, 2018 - RxTE Health (RxTE), a company specializing in pharmacy cost reduction programs for employers, today announced the appointment of Dave Teckman as Executive Chairman of the Board. In this role, Teckman will be responsible for overseeing business development, sales, marketing, and operational activities for RxTE.
Teckman brings nearly four decades of sales, marketing and leadership experience to his role at RxTE. Prior to joining RxTE, Teckman was the Executive Vice President of Marketing and Sales for Advanced Infusion Solutions. Before that, Teckman was President and Chief Executive Officer at several pharmaceutical and healthcare technology companies, including PharmaGenoma Inc., Sutura Inc., and Vivius. Teckman earned his Bachelor of Science in business administration from Miami University in Oxford, Ohio.
RxTE Health saw tremendous momentum this past year and with increasing demand for our innovative pharmacy benefit solutions, we needed to add a seasoned healthcare executive to our team to help us scale operations, said David Henka, President and CEO of RxTE. With extensive knowledge of the complex inner workings of the pharmaceutical and life sciences industries and years of experience leading marketing and business development initiatives, we are confident that Dave will be a true asset to our business and help drive the trajectory of RxTE Health.
RxTE works with employers across the country to implement reference pricing, an innovative payment model proven to significantly move the needle on healthcares fastest growing (and third largest) cost driver: pharmaceuticals. Using a propriety algorithm, RxTE leverages insurer/employer contributions and economic incentives to encourage patients to select less expensive drugs that are biologically equivalent to their name-brand counterparts. RxTEs solution drives average savings of 20 percent per year on pharmacy plans.
It is an exciting time to join this company as--while the entire industry is focused on reducing the cost of prescriptions drugs--RxTE has a model and proven solutions that is actually bending the cost curve in healthcare, said Teckman. I look forward to helping develop and implement the marketing strategies and innovations that will bring RxTEs program to the attention of employers, benefit managers, and every group looking to reduce their pharmaceutical spend.
About RxTE Health
Since 2010, RxTE Health (RxTE) has worked with some of the countrys largest employers across multiple industries, including unions and trusts, to effectively drive down pharmacy costs. RxTE leverages a reference pricing model which applies a proprietary algorithm scientifically proven to drive immediate and ongoing savings of more than 20 percent, while also empowering members and their doctors to select the most cost-effective drug treatment. To start lowering costs, increase benefit plan adherence and improve the well-being of employees, visit www.rxtehealth.com.
###
Media Contact:
Ashley Owen
Aria Marketing for RxTE Health
(617) 332-9999 x 216